To further investigate the interplay between tumor cells and T cells in the adapted model microenvironment, we proceeded with a comparison of the anti-tumor efficacy of an anti-PD-L1 antibody between the original/129 group and the adapted/B6 group. This evidence concerns the gene CD274 and neoplasm.